Carnegie Pharmaceuticals LLC
Murali Krishna Timmisetty is an experienced analytical development scientist currently employed at Cambrex since February 2022 and serves as an R&D analytical chemist at Carnegie Pharmaceuticals LLC since August 2017. Murali Krishna holds two master's degrees in Pharmacology and Toxicology, both obtained from Wright State University, with studies completed at the Wright State University Boonshoft School of Medicine in 2015 and at Wright State University from 2015 to 2017.
This person is not in any teams
Carnegie Pharmaceuticals LLC
Carnegie Pharmaceuticals specializes in the development of unique generic and branded products possessing development barriers. The founder, Dr. Rakesh Grover, have the experience of developing a number of challenging products including patent challenges and setting up vertically integrated pharmaceutical companies that manufacture active raw materials, finished dosage forms and sell the finished products in the United States as well as globally. At Carnegie, a team of highly skilled and experienced scientists are developing challenging products using in-house technology platforms, technical know-how and prior experience. Carnegie is constantly seeking partnerships with individuals and companies to develop a portfolio of challenging and exciting projects.